Xu Xu, Zhang Lian-Xin, Jiang Jing-Jing
National Center for Children's Health, MOE Key Laboratory of Major Diseases in Children, Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
Int J Ophthalmol. 2025 Mar 18;18(3):415-419. doi: 10.18240/ijo.2025.03.07. eCollection 2025.
To compare the efficacy of different administration regimens of compound tropicamide eyedrops (CTE) for pupil dilation for children with dark iris.
A prospective, comparative, randomized interventional study was conducted. Children in Group 1 received CTE 3 times with a 3min interval between each application. Children in Group 2 received CTE 4 times with a 5min interval between each application. We measured their pupil diameters at baseline (pre-drug instillation) and 30min and 60min post-drug instillation and assessed the pupillary light reflex at 60min post-drug instillation.
In total, 194 eyes of 101 children were enrolled. The changes of pupil diameter at 30min and 60min post-drug instillation were 1.2±0.6 mm and 2.3±1.0 mm in Group 1, and 2.3±0.9 mm and 3.7±1.0 mm in Group 2, respectively. Group 2 showed a larger change in pupil size than Group 1 at 30min (<0.01) and 60min (<0.01). The effect of pupil dilation in Group 2 was 1.25 times that in Group 1. The change in pupil size was positively associated with age. A higher proportion of children in Group 1 had smaller pupil diameter and reactive pupils at the final time point, with only 33 children (33.7%) had final pupil size ≥6.5 mm, and only 9 children (9.2%) had non-reactive pupils. Children in Group 2 achieved larger pupil diameter and more non-reactive pupils at the final time point, with 84 children (87.5%) had final pupil size ≥6.5 mm, and only 22 children (22.9%) had reactive pupils.
Increasing the frequency of compound tropicamide and lengthening the interval between eye drop applications can produce stronger mydriatic effects.
比较复方托吡卡胺滴眼液(CTE)不同给药方案对深色虹膜儿童散瞳的疗效。
进行一项前瞻性、比较性、随机干预研究。第1组儿童每隔3分钟滴用CTE 1次,共滴3次。第2组儿童每隔5分钟滴用CTE 1次,共滴4次。在基线(滴药前)、滴药后30分钟和60分钟测量瞳孔直径,并在滴药后60分钟评估瞳孔对光反射。
共纳入101名儿童的194只眼。第1组滴药后30分钟和60分钟瞳孔直径变化分别为1.2±0.6毫米和2.3±1.0毫米,第2组分别为2.3±0.9毫米和3.7±1.0毫米。第2组在30分钟(<0.01)和60分钟(<0.01)时瞳孔大小变化比第1组大。第2组散瞳效果是第1组的1.25倍。瞳孔大小变化与年龄呈正相关。第1组中较高比例的儿童在最后时间点瞳孔直径较小且瞳孔有反应,仅33名儿童(33.7%)最终瞳孔大小≥6.5毫米,仅9名儿童(9.2%)瞳孔无反应。第2组儿童在最后时间点瞳孔直径更大且更多儿童瞳孔无反应,84名儿童(87.5%)最终瞳孔大小≥6.5毫米,仅22名儿童(22.9%)瞳孔有反应。
增加复方托吡卡胺的使用频率并延长滴眼间隔时间可产生更强的散瞳效果。